Treatment Trends of Myocarditis with Coxsackievirus B3 infection

  • Dalya Basil Hanna Department of Clinical Laboratory Sciences, College of Pharmacy, Mustansiriyah University, Baghdad, Iraq.
  • Ghaith Ali Jasim Department of Pharmacology and Toxicology, College of Pharmacy, Mustansiriyah University, Baghdad, Iraq
  • Arwa Mujahid Abdullah Al-Shuwaikh Department of Microbiology, College of Medicine, Al-Nahrain University, Baghdad, Iraq


Viral myocarditis occurred after viral invasion of the cardiocytes and followed by the releasing of viral particles and inflammatory cells. Acute viral myocarditis is relatively common phase of the disease cured spontaneously in some cases or leading to sever acute heart failure and cardiac damage ended with chronic heart failure with increased mortality rate. The fully understand mechanism of viral myocarditis is unclear but some hypothesis trying to illustrate the events of the disease.

Regardless of etiological cause, myocarditis is treated depending on disease phase and by following the instructions of Heart Failure Society of America guideline.

This article provides the basic knowledge available in literatures to review some important informations of viral myocarditis, with a special focusing on viral myocarditis caused by coxsackievirus B3 infection.

How to Cite
HANNA, Dalya Basil; JASIM, Ghaith Ali; ABDULLAH AL-SHUWAIKH, Arwa Mujahid. Treatment Trends of Myocarditis with Coxsackievirus B3 infection. Al-Mustansiriyah Journal of Pharmaceutical Sciences (AJPS), [S.l.], v. 20, n. 2, p. 19- 30, june 2020. ISSN 1815-0993. Available at: <>. Date accessed: 24 sep. 2021.